This week, GSK made a formal request asking the court to consolidate the multiple
Zofran birth defect lawsuits into a multi-district litigation (MDL) to be heard
before one judge in Pennsylvania, where GSK's U.S. headquarters is located.
So far, there have been 12 lawsuits filed against GSK regarding its drug
Zofran in eight states. Each of the lawsuits claim that mothers who took
Zofran to treat morning sickness during their first trimester delivered
babies with birth defects ranging from cleft palate and cleft lip to holes
in the heart. The lawsuits allege that the defects were a direct result
of taking Zofran, and that GSK both failed to warn women of the risks
and improperly marketed the drug to pregnant women.
Consolidating cases into MDLs is common in mass tort / drug injury cases
where companies anticipate receiving numerous lawsuits claiming similar
issues. For existing Zofran cases, should the MDL be granted, this means
that the cases will simply change venues. For all subsequent Zofran lawsuits,
they will join the MDL heard by the singular judge in Pennsylvania.
Domina Law Group attorneys are currently handling a Zofran birth defect
case and will accept more in Nebraska or elsewhere. If you or someone
you know took Zofran for morning sickness and your baby developed a birth
defect, we invite you to contact us today for a review of your case.